Vasiliki Zolota

About Vasiliki Zolota

Vasiliki Zolota, With an exceptional h-index of 31 and a recent h-index of 15 (since 2020), a distinguished researcher at University of Patras, specializes in the field of Study of intracellular signalling pathways and epigenetic aberrations of human cancer.

His recent articles reflect a diverse array of research interests and contributions to the field:

The Immunohistochemical Expression of REV-7 in Various Human Cancer Pathology Specimens: A Systematic Review

A comprehensive analysis of GATA3 expression in carcinomas of various origins with emphasis on lung carcinomas

Delayed diagnosis of a primary diffuse large B-cell lymphoma of the humeral head, presenting as pathological fracture: a case report and review of the literature

Prognostic value of histopathologic traits independent of stromal tumor-infiltrating lymphocyte levels in chemotherapy-naïve patients with triple-negative breast cancer

Altered Expression of Intestinal Tight Junctions in Patients with Chronic Kidney Disease: A Pathogenetic Mechanism of Intestinal Hyperpermeability

Lineage Plasticity and Stemness Phenotypes in Prostate Cancer: Harnessing the Power of Integrated “Omics” Approaches to Explore Measurable Metrics

Ras suppressor-1 (RSU1) exerts a tumor suppressive role with prognostic significance in lung adenocarcinoma

# 4884 DISRUPTION OF THE INTESTINAL MUCOSAL BARRIER IN CHRONIC KIDNEY DISEASE IS RELATED TO REDUCED EXPRESSION OF THE TIGHT JUNCTIONS'COMPONENTS

Vasiliki Zolota Information

University

Position

Department of Pathology Medical School

Citations(all)

3243

Citations(since 2020)

1072

Cited By

2521

hIndex(all)

31

hIndex(since 2020)

15

i10Index(all)

76

i10Index(since 2020)

23

Email

University Profile Page

Google Scholar

Vasiliki Zolota Skills & Research Interests

Study of intracellular signalling pathways and epigenetic aberrations of human cancer

Top articles of Vasiliki Zolota

The Immunohistochemical Expression of REV-7 in Various Human Cancer Pathology Specimens: A Systematic Review

2024/1/19

Eleni Zografos
Eleni Zografos

H-Index: 6

Vasiliki Zolota
Vasiliki Zolota

H-Index: 14

A comprehensive analysis of GATA3 expression in carcinomas of various origins with emphasis on lung carcinomas

Monaldi Archives for Chest Disease

2024

Vasiliki Zolota
Vasiliki Zolota

H-Index: 14

Delayed diagnosis of a primary diffuse large B-cell lymphoma of the humeral head, presenting as pathological fracture: a case report and review of the literature

JSES Reviews, Reports & Techniques

2024/1/26

Prognostic value of histopathologic traits independent of stromal tumor-infiltrating lymphocyte levels in chemotherapy-naïve patients with triple-negative breast cancer

ESMO open

2024/3/1

Altered Expression of Intestinal Tight Junctions in Patients with Chronic Kidney Disease: A Pathogenetic Mechanism of Intestinal Hyperpermeability

Biomedicines

2024/2/5

Lineage Plasticity and Stemness Phenotypes in Prostate Cancer: Harnessing the Power of Integrated “Omics” Approaches to Explore Measurable Metrics

2023/9/1

Eugenia Papadaki
Eugenia Papadaki

H-Index: 4

Vasiliki Zolota
Vasiliki Zolota

H-Index: 14

Ras suppressor-1 (RSU1) exerts a tumor suppressive role with prognostic significance in lung adenocarcinoma

Clinical and Experimental Medicine

2023/7

# 4884 DISRUPTION OF THE INTESTINAL MUCOSAL BARRIER IN CHRONIC KIDNEY DISEASE IS RELATED TO REDUCED EXPRESSION OF THE TIGHT JUNCTIONS'COMPONENTS

Nephrology Dialysis Transplantation

2023/6

Bioenergetic Profiling in Glioblastoma Multiforme Patients with Different Clinical Outcomes

Metabolites

2023/2/28

Vasiliki Zolota
Vasiliki Zolota

H-Index: 14

Dimitrios Kardamakis
Dimitrios Kardamakis

H-Index: 16

ONEST (observers needed to evaluate subjective tests) analysis of stromal tumour-infiltrating lymphocytes (sTILs) in breast cancer and its limitations

Cancers

2023/2/14

P060 Restoration of occludin and claudin-1 expression in patients with Crohn’s disease receiving anti-TNF treatment.

Journal of Crohn's and Colitis

2023/2/1

Elucidating the role of PRMTs in prostate cancer using open access databases and a patient cohort dataset

2023

Altered adipokine expression in tumor microenvironment promotes development of triple negative breast cancer

2022/8/26

Zoi Piperigkou
Zoi Piperigkou

H-Index: 17

Vasiliki Zolota
Vasiliki Zolota

H-Index: 14

The microRNA-Extracellular Matrix Interplay in Breast Cancer

2022/7/7

Zoi Piperigkou
Zoi Piperigkou

H-Index: 17

Vasiliki Zolota
Vasiliki Zolota

H-Index: 14

Diagnostic and Therapeutic Challenges in a Patient with Ureteral Metastases from a Triple Negative Breast Cancer

Current Oncology

2022/7/7

Vasiliki Zolota
Vasiliki Zolota

H-Index: 14

Dimitrios Kardamakis
Dimitrios Kardamakis

H-Index: 16

Prognostic value of stromal tumor-infiltrating lymphocytes in young, node-negative, triple-negative breast cancer patients who did not receive (neo) adjuvant systemic therapy

Journal of Clinical Oncology

2022/7/7

A 3-miRNA Signature Enables Risk Stratification in Glioblastoma Multiforme Patients with Different Clinical Outcomes

Current Oncology

2022/6/16

Vasiliki Zolota
Vasiliki Zolota

H-Index: 14

Dimitrios Kardamakis
Dimitrios Kardamakis

H-Index: 16

ESR2 Drives Mesenchymal-to-Epithelial Transition in Triple-Negative Breast Cancer and Tumorigenesis In Vivo

Frontiers in Oncology

2022/6/3

Synchronous development of intrahepatic cholangiocarcinoma and MALT lymphoma of the liver with chronic B-viral hepatitis

European Journal of Surgical Oncology

2022/2/1

Vasiliki Zolota
Vasiliki Zolota

H-Index: 14

Intra-tumour heterogeneity is one of the main sources of inter-observer variation in scoring stromal tumour infiltrating lymphocytes in triple negative breast cancer

Cancers

2021/8/31

See List of Professors in Vasiliki Zolota University(University of Patras)